Suven Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹248.85Cr
Net Profits
₹60.77Cr
Net Profit Margins
24.42%

Highlights

Revenue:

Suven Pharmaceuticals Ltd’s revenue fell -30.53% since last year same period to ₹248.85Cr in the Q1 2024-2025. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated -7.83% fall in its revenue since last 3-months.

Net Profits:

Suven Pharmaceuticals Ltd’s net profit fell -49.61% since last year same period to ₹60.77Cr in the Q1 2024-2025. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated 13.87% jump in its net profits since last 3-months.

Net Profit Margins:

Suven Pharmaceuticals Ltd’s net profit margin fell -27.46% since last year same period to 24.42% in the Q1 2024-2025. On a quarterly growth basis, Suven Pharmaceuticals Ltd has generated 23.53% jump in its net profit margins since last 3-months.

FAQs

The revenue for Suven Pharmaceuticals Ltd in the Q1 results 2024 was ₹248.85Cr.

The net profit for Suven Pharmaceuticals Ltd in the Q1 results 2024 was ₹60.77Cr.

The net profit margin for Suven Pharmaceuticals Ltd in the Q1 results 2024 was 24.42%.

The revenue for Suven Pharmaceuticals Ltd in the Q1 results 2023 was ₹358.22Cr.

The net profit for Suven Pharmaceuticals Ltd in the Q1 results 2023 was ₹120.59Cr.

The net profit margin for Suven Pharmaceuticals Ltd in the Q1 results 2023 was 33.66%.